4Parkin D M, Bray F I, Devesa $ S.Cancer burden in the year 2000, the global picture[J].Eur J Cancer, 2001, 37(8):4-6.
5Choudhury A, Palma M, Mellstedt H.The future of cancer vaccines for non-small cell lung cancer: Ongoing trials[J].Clin Lung Cancer, 2008, 9(1):37-44.
6Tuyaerts S, Van Meirvenne S, Bonehill A, et al.Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells[J].J Leuko Biu, 2007, 82(1):93-105.
7Ilett E J, Prestwich RJ, Melcher AA. The evolving role of dendritic cells incancer therapy[ J]. Expert Opin Biol Ther,2010,10 ( 3 ) : 369 - 379.
8Niam M, Linn YC, Fook Chong S, et al. Clinical scale expansion of cytokine- induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy[J]. Exp Hematol,2011,39(9) :897 -903.
9Wongkajornsilp A, Somchitprasert T, Butraporn R, et al. Human cy- tokine - induced killer cells specifically infiltrated and retarded the growth of the inoculated human eholangiocarcinoma cells in SCID mice[ J]. Cancer Invest,2009,27 (2) : 140 - 148.
